Company intelligence / Profile preview

Arizona Cancer Therapeutics

Tucson, Arizona, United States

Ownership: Private
Development stage: Other

Overview

Arizona Cancer Therapeutics is a biotechnology company focused on developing novel small molecule therapeutics for the treatment of difficult-to-treat cancers. The company's lead programs target G-quadruplex DNA structures to modulate the expression of key oncogenes such as MYC and HIF-1a, which are frequently overexpressed in aggressive malignancies. By utilizing a precision medicine approach, Arizona Cancer Therapeutics aims to disrupt the transcriptional drivers of tumor growth and survival. The company is currently advancing its candidates through pre-clinical development with a primary focus on indications like pancreatic and colorectal cancer.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Partnerships

University of Arizona

Beyond the preview

Go deeper on Arizona Cancer Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arizona Cancer Therapeutics.

Explore the full profile